Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer

Kazuhiro Kitajima, Koji Murakami, Erena Yamasaki, Yasushi Domeki, Yasushi Kaji, Kazuro Sugimura

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The purpose is to evaluate the accuracy of integrated FDG-PET/CT, compared with PET alone, for diagnosis of suspected recurrence of uterine cervical cancer. Fifty-two women who had undergone treatment for histopathologically proven cervical cancer received PET/CT with suspected recurrence. PET-alone and integrated PET/CT images were evaluated by two different experienced radiologists by consensus for each investigation. A final diagnosis was confirmed by histopathology, radiological imaging, and clinical follow-up for over 1 year. Patient-based analysis showed that the sensitivity, specificity, and accuracy of PET/CT were 92.0% (23/25), 92.6% (25/27), and 92.3% (48/52), respectively, while for PET, the corresponding figures were 80.0% (20/ 25), 77.8% (21/27), and 78.8% (41/52), respectively. PET/CT resolved the false-positive PET results due to hypermetabolic activity of benign/ inflammatory lesions and physiological variants, and was able to detect lung metastasis, local recurrence, peritoneal dissemination, para-aortic lymph node metastasis, and pelvic lymph node metastasis missed by PET alone. However, tiny local recurrence and lymph node metastasis could not be detected even by PET/CT. FDG-PET/CT is a useful complementary modality for providing good anatomic and functional localization of sites of recurrence during follow-up of patients with cervical cancer.

Original languageEnglish
Pages (from-to)2040-2047
Number of pages8
JournalEuropean Radiology
Volume18
Issue number10
DOIs
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Uterine Cervical Neoplasms
Recurrence
Neoplasm Metastasis
Lymph Nodes
Sensitivity and Specificity
Lung
Therapeutics

Keywords

  • F-FDG
  • Cervical cancer
  • PET/CT
  • Recurrence

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Kitajima, K., Murakami, K., Yamasaki, E., Domeki, Y., Kaji, Y., & Sugimura, K. (2008). Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer. European Radiology, 18(10), 2040-2047. https://doi.org/10.1007/s00330-008-0979-9

Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer. / Kitajima, Kazuhiro; Murakami, Koji; Yamasaki, Erena; Domeki, Yasushi; Kaji, Yasushi; Sugimura, Kazuro.

In: European Radiology, Vol. 18, No. 10, 2008, p. 2040-2047.

Research output: Contribution to journalArticle

Kitajima, K, Murakami, K, Yamasaki, E, Domeki, Y, Kaji, Y & Sugimura, K 2008, 'Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer', European Radiology, vol. 18, no. 10, pp. 2040-2047. https://doi.org/10.1007/s00330-008-0979-9
Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Sugimura K. Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer. European Radiology. 2008;18(10):2040-2047. https://doi.org/10.1007/s00330-008-0979-9
Kitajima, Kazuhiro ; Murakami, Koji ; Yamasaki, Erena ; Domeki, Yasushi ; Kaji, Yasushi ; Sugimura, Kazuro. / Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer. In: European Radiology. 2008 ; Vol. 18, No. 10. pp. 2040-2047.
@article{4a5364da70bd4a24baddfb483bbc38eb,
title = "Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer",
abstract = "The purpose is to evaluate the accuracy of integrated FDG-PET/CT, compared with PET alone, for diagnosis of suspected recurrence of uterine cervical cancer. Fifty-two women who had undergone treatment for histopathologically proven cervical cancer received PET/CT with suspected recurrence. PET-alone and integrated PET/CT images were evaluated by two different experienced radiologists by consensus for each investigation. A final diagnosis was confirmed by histopathology, radiological imaging, and clinical follow-up for over 1 year. Patient-based analysis showed that the sensitivity, specificity, and accuracy of PET/CT were 92.0{\%} (23/25), 92.6{\%} (25/27), and 92.3{\%} (48/52), respectively, while for PET, the corresponding figures were 80.0{\%} (20/ 25), 77.8{\%} (21/27), and 78.8{\%} (41/52), respectively. PET/CT resolved the false-positive PET results due to hypermetabolic activity of benign/ inflammatory lesions and physiological variants, and was able to detect lung metastasis, local recurrence, peritoneal dissemination, para-aortic lymph node metastasis, and pelvic lymph node metastasis missed by PET alone. However, tiny local recurrence and lymph node metastasis could not be detected even by PET/CT. FDG-PET/CT is a useful complementary modality for providing good anatomic and functional localization of sites of recurrence during follow-up of patients with cervical cancer.",
keywords = "F-FDG, Cervical cancer, PET/CT, Recurrence",
author = "Kazuhiro Kitajima and Koji Murakami and Erena Yamasaki and Yasushi Domeki and Yasushi Kaji and Kazuro Sugimura",
year = "2008",
doi = "10.1007/s00330-008-0979-9",
language = "English",
volume = "18",
pages = "2040--2047",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer

AU - Kitajima, Kazuhiro

AU - Murakami, Koji

AU - Yamasaki, Erena

AU - Domeki, Yasushi

AU - Kaji, Yasushi

AU - Sugimura, Kazuro

PY - 2008

Y1 - 2008

N2 - The purpose is to evaluate the accuracy of integrated FDG-PET/CT, compared with PET alone, for diagnosis of suspected recurrence of uterine cervical cancer. Fifty-two women who had undergone treatment for histopathologically proven cervical cancer received PET/CT with suspected recurrence. PET-alone and integrated PET/CT images were evaluated by two different experienced radiologists by consensus for each investigation. A final diagnosis was confirmed by histopathology, radiological imaging, and clinical follow-up for over 1 year. Patient-based analysis showed that the sensitivity, specificity, and accuracy of PET/CT were 92.0% (23/25), 92.6% (25/27), and 92.3% (48/52), respectively, while for PET, the corresponding figures were 80.0% (20/ 25), 77.8% (21/27), and 78.8% (41/52), respectively. PET/CT resolved the false-positive PET results due to hypermetabolic activity of benign/ inflammatory lesions and physiological variants, and was able to detect lung metastasis, local recurrence, peritoneal dissemination, para-aortic lymph node metastasis, and pelvic lymph node metastasis missed by PET alone. However, tiny local recurrence and lymph node metastasis could not be detected even by PET/CT. FDG-PET/CT is a useful complementary modality for providing good anatomic and functional localization of sites of recurrence during follow-up of patients with cervical cancer.

AB - The purpose is to evaluate the accuracy of integrated FDG-PET/CT, compared with PET alone, for diagnosis of suspected recurrence of uterine cervical cancer. Fifty-two women who had undergone treatment for histopathologically proven cervical cancer received PET/CT with suspected recurrence. PET-alone and integrated PET/CT images were evaluated by two different experienced radiologists by consensus for each investigation. A final diagnosis was confirmed by histopathology, radiological imaging, and clinical follow-up for over 1 year. Patient-based analysis showed that the sensitivity, specificity, and accuracy of PET/CT were 92.0% (23/25), 92.6% (25/27), and 92.3% (48/52), respectively, while for PET, the corresponding figures were 80.0% (20/ 25), 77.8% (21/27), and 78.8% (41/52), respectively. PET/CT resolved the false-positive PET results due to hypermetabolic activity of benign/ inflammatory lesions and physiological variants, and was able to detect lung metastasis, local recurrence, peritoneal dissemination, para-aortic lymph node metastasis, and pelvic lymph node metastasis missed by PET alone. However, tiny local recurrence and lymph node metastasis could not be detected even by PET/CT. FDG-PET/CT is a useful complementary modality for providing good anatomic and functional localization of sites of recurrence during follow-up of patients with cervical cancer.

KW - F-FDG

KW - Cervical cancer

KW - PET/CT

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=52049116307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52049116307&partnerID=8YFLogxK

U2 - 10.1007/s00330-008-0979-9

DO - 10.1007/s00330-008-0979-9

M3 - Article

C2 - 18425518

AN - SCOPUS:52049116307

VL - 18

SP - 2040

EP - 2047

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 10

ER -